Top Transparency Reporting Mistakes Pharmaceutical Companies Should Avoid

Strengthening Compliance, Reducing Risk, and Improving Disclosure Accuracy

Transparency reporting is no longer just a regulatory obligation—it is a critical component of ethical business practices, corporate governance, and regulatory compliance. Across the UK and Europe, pharmaceutical and biotechnology companies are expected to accurately disclose transfers of value to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs), while maintaining robust documentation and audit-ready processes.

For many organisations, particularly those with lean compliance teams, reporting challenges often arise from fragmented processes, inconsistent data, manual workflows, and limited cross-functional coordination rather than deliberate non-compliance. Addressing these issues early helps reduce compliance risk, improve operational efficiency, and strengthen stakeholder trust.

Common Transparency Reporting Mistakes

Treating Transparency as a Year-End Exercise

Transparency begins when an HCP engagement is planned—not when disclosures are due. Delayed data collection often leads to reporting errors, missing documentation, and time-consuming reconciliations.

Incomplete HCP Information and Supporting Documentation

Missing HCP details, contracts, or Fair Market Value (FMV) documentation can delay disclosures and make payments difficult to justify during audits or inspections.

Poor Cross-Functional Collaboration

Effective transparency reporting relies on seamless collaboration between Medical Affairs, Commercial, Finance, Procurement, and Compliance. Siloed working practices often result in inconsistent data and duplicated effort.

Overlooking Local Disclosure Requirements

Transparency requirements differ across countries. Applying a single global process without accounting for local regulations and industry codes can increase compliance risk.

Manual Processes and Weak Data Governance

Spreadsheet-driven reporting and inconsistent master data create unnecessary administrative burden, increase the risk of reporting errors, and reduce audit readiness as organisations grow.

Misclassification of Transfers of Value

Incorrectly categorising consultancy fees, sponsorships, educational grants, or research-related payments can result in inaccurate disclosures and increased regulatory scrutiny.

Building a Robust Transparency Framework

A successful transparency programme is built on strong governance, standardised processes, accurate data, and continuous monitoring throughout the HCP engagement lifecycle. Organisations that embed transparency into everyday operations benefit from improved reporting accuracy, stronger compliance, greater audit readiness, and more efficient use of internal resources.

For many small and mid-sized pharmaceutical companies, partnering with a specialist compliance provider offers access to scalable operating models, industry expertise, and technology-enabled solutions without the need to expand internal compliance teams.

How Eunomia Pharma Services Can Help

Eunomia Pharma Services supports pharmaceutical and biotechnology companies across the UK and Europe with practical, scalable transparency and disclosure solutions, including:

• Transparency Reporting & Disclosure Management
• HCP Engagement Governance
• Fair Market Value (FMV) Assessments
• Global & Local Materials Review
• Local Representative Services / RIP Services
• Compliance Operating Model Assessments
• Shared Services, GCC & GBS Compliance Support

Our technology-enabled approach helps organisations improve reporting accuracy, strengthen governance, reduce administrative burden, and maintain audit-ready compliance programmes.

Conclusion

An effective transparency programme is about more than meeting disclosure deadlines—it is about building trust, strengthening governance, and supporting sustainable business growth.

By investing in robust processes and expert compliance support, pharmaceutical companies can reduce regulatory risk, improve operational efficiency, and confidently navigate evolving UK and European transparency requirements.

Looking to optimise your transparency reporting process? Contact Eunomia Pharma Services to learn how our tailored compliance solutions can help your organisation build an accurate, efficient, and audit-ready transparency programme.